Generation of natural killer cells from serum-free, expanded human umbilical cord blood CD34+ cells

被引:42
作者
Kao, I-Ting [1 ]
Yao, Chao-Ling [1 ]
Kong, Zwe-Ling [2 ]
Wu, Mei-Ling [1 ]
Chuang, Tzu-Lin [1 ]
Hwang, Shiaw-Min [1 ]
机构
[1] Food Ind Res & Dev Inst, Bioresource Collect & Res Ctr, Hsinchu 30062, Taiwan
[2] Natl Taiwan Ocean Univ, Dept Food Sci, Cellular Immunol Lab, Chilung, Taiwan
关键词
D O I
10.1089/scd.2007.0033
中图分类号
Q813 [细胞工程];
学科分类号
摘要
Natural killer (NK) cells are important effectors of the innate immune system, which exhibits cytolytic activity against infectious agents and tumor cells. NK cells are derived from CD34(+) hematopoietic stem cells (HSCs). Human umbilical cord blood (UCB) has been recognized as a rich source of HSCs. Previously, we have reported an optimized serum-free medium for ex vivo expansion of CD34(+) cells from UCB. In this study, the serum-free, expanded CD34(+) cells were tested to differentiate into NK cells and their induction kinetics. After 5 weeks of induction, the induced NK cells were characterized by analysis of surface antigens, IFN-gamma secretion, and cytotoxicity against K562 cells. The results indicated that NK cells derived from the serum-free, expanded CD34(+) cells exhibited both characteristics and functions of NK cells. Furthermore, the serum-free, expanded CD34(+) cells showed a significantly higher NK cell differentiation potential than freshly isolated CD34(+) cells. NK cells induced from serum-free, expanded CD34(+) cells showed a higher concentration of IFN-gamma secretion and ability of cytotoxicity than those from freshly isolated CD34(+) cells. Therefore, ex vivo-expanded CD34(+) cells in optimized serum-free medium could differentiate into NK cells and provided a promising cell source for immunotherapeutic approaches.
引用
收藏
页码:1043 / 1051
页数:9
相关论文
共 33 条
[1]  
Carayol G, 1998, EUR J IMMUNOL, V28, P1991, DOI 10.1002/(SICI)1521-4141(199806)28:06<1991::AID-IMMU1991>3.0.CO
[2]  
2-7
[3]  
Carson William, 1996, Methods (Orlando), V9, P327, DOI 10.1006/meth.1996.0038
[4]   Role of interleukin-2 (IL-2), IL-7, and IL-15 in natural killer cell differentiation from cord blood hematopoietic progenitor cells and from gamma c transduced severe combined immunodeficiency XI bone marrow cells [J].
CavazzanaCalvo, M ;
HaceinBey, S ;
Basile, GD ;
DeCoene, C ;
Selz, F ;
LeDeist, F ;
Fischer, A .
BLOOD, 1996, 88 (10) :3901-3909
[5]   What does it take to make a natural killer? [J].
Colucci, F ;
Caligiuri, MA ;
Di Santo, JP .
NATURE REVIEWS IMMUNOLOGY, 2003, 3 (05) :413-425
[6]   The biology of human natural killer-cell subsets [J].
Cooper, MA ;
Fehniger, TA ;
Caligiuri, MA .
TRENDS IN IMMUNOLOGY, 2001, 22 (11) :633-640
[7]   Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect [J].
Farag, SS ;
Fehniger, TA ;
Ruggeri, L ;
Velardi, A ;
Caligiuri, MA .
BLOOD, 2002, 100 (06) :1935-1947
[8]   Interleukin 15: biology and relevance to human disease [J].
Fehniger, TA ;
Caligiuri, MA .
BLOOD, 2001, 97 (01) :14-32
[9]   Presence of primitive lymphoid progenitors with NK or B potential in ex vivo expanded bone marrow cell cultures [J].
Giarratana, MC ;
Vergé, V ;
Schmitt, C ;
Bertho, JM ;
Kobari, L ;
Barret, C ;
Douay, L .
EXPERIMENTAL HEMATOLOGY, 2000, 28 (01) :46-54
[10]   Current status of umbilical cord blood hematopoietic stem cell transplantation [J].
Gluckman, E .
EXPERIMENTAL HEMATOLOGY, 2000, 28 (11) :1197-1205